[1] |
BARZAMAN K, MORADI-KALBOLANDI S, HOSSEINZADEH A, et al. Breast cancer immunotherapy: current and novel approaches[J]. Int Immunopharmacol, 2021, 98: 107886.
|
[2] |
CHHABRA N, KENNEDY J. A review of cancer immunotherapy toxicity: immune checkpoint inhibitors[J]. J Med Toxicol, 2021, 17(4): 411-424.
doi: 10.1007/s13181-021-00833-8
|
[3] |
CHEN C, WU B, ZHANG C Y, et al. Immune-related adverse events associated with immune checkpoint inhibitors: an updated comprehensive disproportionality analysis of the FDA adverse event reporting system[J]. Int Immunopharmacol, 2021, 95: 107498.
|
[4] |
GODBERT B, PETITPAIN N, LOPEZ A, et al. Hepatitis B reactivation and immune check point inhibitors[J]. Dig Liver Dis, 2021, 53(4): 452-455.
doi: 10.1016/j.dld.2020.08.041
|
[5] |
EDERHY S, VOISIN A L, CHAMPIAT S. Myocarditis with immune checkpoint blockade[J]. N Engl J Med, 2017, 376(3): 290-291.
doi: 10.1056/NEJMc1615251
|
[6] |
付国强, 曹义战, 何乾锋, 等. N-3不饱和脂肪酸对C57BL/6 PD-1基因敲除小鼠心房结构重构的影响[J]. 山西医科大学学报, 2016, 47(1): 1-5.
|
|
FU G Q, CAO Y Z, HE Q F, et al. Effects of N-3 polyunsaturated fatty acids on atrial structure remodeling by inhibiting atrial myocytes oxidative stress in C57BL/6 PD-1-/- mice[J]. J Shanxi Med Univ, 2016, 47(1): 1-5.
|
[7] |
CHEN Y X, LIU Y Z, WANG Y, et al. Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages[J]. J Exp Clin Cancer Res, 2022, 41(1): 1.
|
[8] |
BUQUÉ A, GALLUZZI L. Modeling tumor immunology and immunotherapy in mice[J]. Trends Cancer, 2018, 4(9): 599-601.
doi: 10.1016/j.trecan.2018.07.003
|
[9] |
TAJIRI K, IMANAKA-YOSHIDA K, TSUJIMURA Y, et al. A new mouse model of chronic myocarditis induced by recombinant bacille calmett-eguèrin expressing a T-cell epitope of cardiac myosin heavy chain-Α[J]. Int J Mol Sci, 2021, 22(2): 794.
|
[10] |
NISHIMURA H, MINATO N, NAKANO T, et al. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses[J]. Int Immunol, 1998, 10(10): 1563-1572.
doi: 10.1093/intimm/10.10.1563
|
[11] |
BOCKSTAHLER M, FISCHER A, GOETZKE C C, et al. Heart-specific immune responses in an animal model of autoimmune-related myocarditis mitigated by an immunoproteasome inhibitor and genetic ablation[J]. Circulation, 2020, 141(23): 1885-1902.
doi: 10.1161/CIRCULATIONAHA.119.043171
|
[12] |
BOCKSTAHLER M, SALBACH C, MÜLLER A M, et al. LNA oligonucleotide mediates an anti-inflammatory effect in autoimmune myocarditis via targeting lactate dehydrogenase B[J]. Immunology, 2022, 165(2): 158-170.
doi: 10.1111/imm.13421
|
[13] |
PALUDAN S R, PRADEU T, MASTERS S L, et al. Constitutive immune mechanisms: mediators of host defence and immune regulation[J]. Nat Rev Immunol, 2021, 21(3): 137-150.
|
[14] |
中国抗癌协会整合肿瘤心脏病学分会, 中华医学会心血管病学分会肿瘤心脏病学学组, 中国医师协会心血管内科医师分会肿瘤心脏病学专业委员会, 等. 免疫检查点抑制剂相关心肌炎监测与管理中国专家共识(2020版)[J]. 中国肿瘤临床, 2020, 47(20): 1027-1038.
|
|
Society of Integrative Cardio-Oncology China Anti-Cancer Association, The Cardio-Oncology Group of The Chinese Society of Cardiovascular Diseases of Chinese Medical Association, Chinese College of Cardiovascular Physicians Specialized Committee on Cardio-Oncology Chinese Medical Docotor Association, et al. Chinese expert consensus on the surveillance and management of immune checkpoint inhibitor-related myocarditis (2020 version)[J]. Chin J Clin Oncol, 2020, 47(20): 1027-1038.
|
[15] |
WEI S C, MEIJERS W C, AXELROD M L, et al. A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis and supports a mechanism-based therapeutic intervention[J]. Cancer Discov, 2021, 11(3): 614-625.
doi: 10.1158/2159-8290.CD-20-0856
|
[16] |
GU X H, LI Y C, CHEN K X, et al. Exosomes derived from umbilical cord mesenchymal stem cells alleviate viral myocarditis through activating AMPK/mTOR-mediated autophagy flux pathway[J]. J Cell Mol Med, 2020, 24(13): 7515-7530.
doi: 10.1111/jcmm.15378
|
[17] |
TAY W T, FANG Y H, BEH S T, et al. Programmed cell death-1: Programmed cell death-ligand 1 interaction protects human cardiomyocytes against T-cell mediated inflammation and apoptosis response in vitro[J]. Int J Mol Sci, 2020, 21(7): E2399.
|
[18] |
CHEN Y X, LIU Y W, XIONG X L, et al. PD-1 inhibitor causes pathological injury to multiple organs in a Lewis lung cancer mouse model[J]. Int Immunopharmacol, 2022, 105: 108551.
|
[19] |
KIM W, CHU T H, NIENHÜSER H, et al. PD-1 signaling promotes tumor-infiltrating myeloid-derived suppressor cells and gastric tumorigenesis in mice[J]. Gastroenterology, 2021, 160(3): 781-796.
doi: 10.1053/j.gastro.2020.10.036
|
[20] |
MARTINI E, KUNDERFRANCO P, PEANO C, et al. Single-cell sequencing of mouse heart immune infiltrate in pressure overload-driven heart failure reveals extent of immune activation[J]. Circulation, 2019, 140(25): 2089-2107.
doi: 10.1161/CIRCULATIONAHA.119.041694
|
[21] |
LONG E, BABL F E, OAKLEY E, et al. Cardiac index changes with fluid bolus therapy in children with sepsis-an observational study[J]. Pediatr Crit Care Med, 2018, 19(6): 513-518.
doi: 10.1097/PCC.0000000000001534
|
[22] |
YU S Y, DONG B, FANG Z F, et al. Knockdown of lncRNA AK139328 alleviates myocardial ischaemia/reperfusion injury in diabetic mice via modulating miR-204-3p and inhibiting autophagy[J]. J Cell Mol Med, 2018, 22(10): 4886-4898.
doi: 10.1111/jcmm.13754
|
[23] |
ZWIRNER J, ANDERS S, BOHNERT S, et al. Screening for fatal traumatic brain injuries in cerebrospinal fluid using blood-validated CK and CK-MB immunoassays[J]. Biomolecules, 2021, 11(7): 1061.
doi: 10.3390/biom11071061
|